Table 1 COVID-19 patients characteristics
From: Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study
Variables | COVID-19 patients (n = 44) | Symptomatic (n = 26) | Asymptomatic (n = 18) |
|---|---|---|---|
Demographics | |||
Age (years) | 59 (22) | 61 (24) | 58 (20) |
Sex (female) | 24 (55%) | 13 (50%) | 11 (61%) |
Comorbidities | |||
BMI (kg·m−2)a | 30 (7) | 29 (5) | 32 (9) |
Diabetes | 11 (25%) | 7 (27%) | 4 (22%) |
Hypertension | 23 (52%) | 13 (50%) | 10 (56%) |
COVID-19 symptoms and treatment at surgery | |||
Positive test at surgery | 42 (96%) | 24 (92%) | 18 (100%) |
Days since positive test (days) | 5 [2, 19] | 8 [2, 20] | 3 [1, 16] |
Cough | 17 (39%) | 17 (65%) | 0 (0%) |
Dyspnea | 13 (30%) | 13 (50%) | 0 (0%) |
Respiratory distress | 9 (21%) | 9 (35%) | 0 (0%) |
Fever | 17 (39%) | 17 (65%) | 0 (0%) |
Antibiotics | 24 (55%) | 19 (73%) | 5 (28%) |
Steroids | 11 (25%) | 9 (35%) | 2 (11%) |
Preoperative respiratory and organ dysfunction | |||
Oxygen | 12 (27%) | 11 (42%) | 1 (6%) |
Mechanical ventilation | 8 (18%) | 8 (31%) | 0 (0%) |
SOFA scoreb | 0 [0, 3] | 1 [0, 6] | 0 [0, 1] |
Surgical characteristics | |||
General anesthesia | 28 (64%) | 18 (69%) | 10 (56%) |
Urgencyc | 31 (71%) | 19 (73%) | 12 (67%) |
Major surgery | 16 (36%) | 9 (35%) | 7 (39%) |
Blood lossd (mL) | 175 [75, 500] | 150 [100, 600] | 250 [50, 300] |